Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine - Drugs.com MedNews
Links shared publicly online about this topic.
- 715total visits
Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine - Drugs.com MedNews
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced successful clinical results from a phase II study of its T-cell vaccine
View full resource at drugs.com
Tags: Vaccination, Allergies, Drug, Vaccine
Most Recently Shared on November 19, 2010 at 9:10 pm By:
Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of ... http://bit.ly/bTnHSG #drug
Advertisement
